Semaglutide is a breakthrough treatment for weight management. It works by reducing appetite, curbing cravings, and helping people feel fuller for longer. Combined with healthy eating and regular activity, it can support significant weight loss while also improving heart health, blood sugar control, and conditions linked to obesity such as sleep apnoea, fatty liver disease, and joint pain.

The management of obesity has advanced with incretin-based therapies. This article compares semaglutide and tirzepatide in weight loss treatments, highlighting clinical evidence, patient considerations, and emerging research in obesity-related health outcomes.